Statens Serum Institut, Denmark
Disclosure information not submitted.
Glucagon-like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study
Tuesday, August 27, 20249:00 AM – 9:15 AM CEST